Disability due to gouty arthritis

Current Opinion in Rheumatology

Volumn 24, Issue 2, 2012, Pages 139-144

  Ten Klooster, Peter M ^a   Vonkeman, Harald E ^a,b   Van De Laar, Mart A F J ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

activity limitation; disability; gout; outcome measures

Indexed keywords

ACCURACY; ALCOHOL CONSUMPTION; BODY WEIGHT; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE EXACERBATION; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SELF CARE; SOCIAL BEHAVIOR; WORK DISABILITY;

ACTIVITIES OF DAILY LIVING; ARTHRITIS, GOUTY; DISABILITY EVALUATION; DISABLED PERSONS; HUMANS; SELF CARE;

EID: 84857039544     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834ff59d     Document Type: Review

References (36)

1. Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N. Chronic gout: Epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 2010; 26:2813-2821.
2. Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: An update. Best Pract Res Clin Rheumatol 2010; 24:811-827.
3. Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 2011; 13:R39.
4. Rothenbacher D, Primatesta P, Ferreira A, et al. Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology (Oxford) 2011; 50:973-981.
5. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: A systematic review of the literature. Curr Opin Rheumatol 2011; 23:192-202.
6. Burns CM, Wortmann RL. Gout therapeutics: New drugs for an old disease. Lancet 2011; 377:165-177.
7. McGill NW. Management of gout: Beyond allopurinol. Intern Med J 2010; 40:545-553.
8. Perry ME, Madhok R. Treatment failure gout: Failure to treat? Rheumatology (Oxford) 2010; 49:2233-2234.
9. Schumacher HR Jr., Edwards LN, Perez-Ruiz F, et al. Outcome measures for acute and chronic gout. J Rheumatol 2005; 32:2452-2455. (Pubitemid 41780667)
10. Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009; 36:2342-2345.
11. Singh JA, Taylor WJ, Simon LS, et al. Patient-reported outcomes in chronic gout: A report from OMERACT 10. J Rheumatol 2011; 38:1452-1457. This article presents the OMERACT-endorsed measures for patient-reported pain, global assessment and activitiy limitation for clinical studies in gout patients. All measures are rated using the OMERACT filter for truth, discrimination, and feasibility.
12. Khanna D, Ahmed M, Yontz D, et al. The disutility of chronic gout. Qual Life Res 2008; 17:815-822.
13. Kim SY, Choi HK. Gout and quality of life. J Rheumatol 2009; 36:865-868.
14. Lindsay K, Gow P, Vanderpyl J, et al. The experience and impact of living with gout: A study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011; 17:1-6. This is the only study to date that thourougly examined the experience of gout from the patients' perspective using a qualitative approach. The study provides detailed insight and striking examples of the impact of gout on both patients and their family. Also, the study shows that patients often experience trivialization and stigmatization which may be a barrier barrier to timely and appropriate medical treatment.
15. Strand V, Crawford B, Singh J, et al. Use of 'spydergrams' to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis 2009; 68:1800-1804.
16. Becker MA, Schumacher HR, Benjamin KL, et al.Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009; 36:1041-1048.
17. Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and healthrelated quality of life among patients with gout. Rheumatology (Oxford) 2009; 48:582-586.
18. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007; 10:231-237. (Pubitemid 47077244)
19. Edwards NL, Sundy JS, Forsythe A, et al. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011; 14:10-15.
20. US Food and Drug Administration. Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD: US Food and Drug Administration; 2009.
21. Wu EQ, Forsythe A, Guerin A, et al. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional uratelowering therapy. Am J Ther 2011 [Epub ahead of print]. doi: 10.1097/ MJT.0b013e31820543c5. A large retrospective cohort study comparing the healthcare utilization of chronic gout patients and matched gout-free controls. The study demonstrated the significant economic burden caused by gout, with gout patients spending over US$ 10 000 more on medical care annually.
22. Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: A retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord 2011; 12:103.
23. Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: Short form-36 is responsive to change in chronic gout. Rheumatology (Oxford) 2011; 50:740-745.
24. Alvarez-Nemegyei J, Cen-Piste JC, Medina-Escobedo M, Villanueva-Jorge S. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout. J Rheumatol 2005; 32:1923-1927. (Pubitemid 41430484)
25. ten Klooster PM, Oude Voshaar MA, Taal E, van de Laar MA. Comparison of measures of functional disability in patients with gout. Rheumatology (Oxford) 2011; 50:709-713. This study simultaneously examined the measurement properties of the HAQ-DI, HAQ-II, and physical functioning 10 in a single sample of gout patients. Results showed that all three measures had adequate reliability and construct valdity, but that they may not be optimally optimally suited for clinical intervention studies.
26. van Groen MM, ten Klooster PM, Taal E, et al. Application of the health assessment questionnaire disability index to various rheumatic diseases. Qual Life Res 2010; 19:1255-1263.
27. Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, et al. Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 2008; 59:665-669. (Pubitemid 351679541)
28. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ 2002; 324:1417.
29. Colwell HH, Hunt BJ, Pasta DJ, et al. Gout Assessment Questionnaire: Initial results of reliability, validity and responsiveness. Int J Clin Pract 2006; 60:1210-1217. (Pubitemid 44375441)
30. Hirsch JD, Lee SJ, Terkeltaub R, et al. Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol 2008; 35: 2406-2414.
31. Khanna D, Sarkin AJ, Khanna PP, et al. Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford) 2011; 50:1331-1336.
32. Beaton DE, Tang K, Gignac MA, et al. Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care Res (Hoboken) 2010; 62:28-37.
33. Roy JS, MacDermid JC, Amick BC 3rd, et al. Validity and responsiveness of presenteeism scales in chronic work-related upper-extremity disorders. Phys Ther 2011; 91:254-266.
34. Tang K. Disease-related differential item functioning in the work instability scale for rheumatoid arthritis: Converging results from three methods. Arthritis Care Res (Hoboken) 2011; 63:1159-1169.
35. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60:34-42. (Pubitemid 44856236)
36. Hewlett S, Smith AP, Kirwan JR. Values for function in rheumatoid arthritis: Patients, professionals, and public. Ann Rheum Dis 2001; 60: 928-933. (Pubitemid 32885666)